UK: PEPTIDE IN TAKEOVER DISCUSSIONS?

Article Abstract:

Peptide Therapeutics, the UK biotechnology company, is thought to be in takeover discussions, although no formal bid has been made. The most likely potential purchasers are Cantab Pharmaceuticals, Oxford Biomedica and Powderject with a Sutherlands Ltd analyst citing Cantab as the most likely prospect. A rise in Peptide's share price on 05 January 2000 on rumours of a possible takeover contrasts with a heavy fall in the share price in the latter part of 1999.

United States, Cantab Pharmaceuticals PLC, Peptide Therapeutics

---

UK: OXFORD BIOMEDICA TO MAKE FULL LISTING

Article Abstract:

Oxford Biomedica has revealed plans for a full listing during the first quarter of 2001. The move from the Alternative Investment Market (AIM) is expected to raise some GB[pound] 30mn for the company. Oxford Biomedica also revealed that it has raised some GB[pound] 8.5mn in the placing of 14.6mn shares at GB[pound] 0.60 each on 10 August 2000. The proceeds will be used to fund a new gene discovery division.

Financial management, Oxford Biomedica, Alternative Investment Market

---

The arranged marriage

Article Abstract:

It is widely believed that the 48 billion pounds sterling all-share merger of UK pharmaceutical concern Zeneca with Astra, its Swedish competitor, will resolve problems at both companies. The deal has already been approved by Zeneca shareholders, and will be ratified by Astra investors in Mar 1999. The merged operation will have sales of 10 billion pounds sterling a year and more than 40,000 employees, making it the third-largest pure pharmaceutical concern in the world. It will have a research and development budget of around $1.9 billion, making it a powerful force in drug development.

Comment:

Has merged with Astra AB

Sweden, Basic Chemical Manufacturing, CHEMICALS AND ALLIED PRODUCTS, Specialty Chemicals, Astra AB, Specialty chemicals industry, Zeneca Ltd.

Similar abstracts:

• Abstracts: UK: RAILTRACK TO RETAIN SAFETY ROLE FOR LONGER. UK: CONCERN OVER RAILTRACK'S NEW POLICY. UK: RAILTRACK OPERATING LICENCE CHANGES?
• Abstracts: UK: HYDER NOT TO APPEAL AGAINST WATER BILL CUTS. UK: FEAR OVER WATER MARKET COMPETITION. UK: WATER REGULATOR FACE FINES ON TURNOVER

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.